Glucotrack (GCTK) EPS (Basic) (2016 - 2020)
Historic EPS (Basic) for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to $0.1.
- Glucotrack's EPS (Basic) rose 110000.0% to $0.1 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.03, marking a year-over-year increase of 17500.0%. This contributed to the annual value of $0.38 for FY2023, which is N/A changed from last year.
- Per Glucotrack's latest filing, its EPS (Basic) stood at $0.1 for Q4 2020, which was up 110000.0% from -$0.03 recorded in Q3 2020.
- In the past 5 years, Glucotrack's EPS (Basic) ranged from a high of $0.48 in Q1 2017 and a low of -$3.78 during Q4 2018
- In the last 5 years, Glucotrack's EPS (Basic) had a median value of -$0.13 in 2016 and averaged -$0.3.
- Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 70425.53% in 2018, then surged by 110000.0% in 2020.
- Quarter analysis of 5 years shows Glucotrack's EPS (Basic) stood at -$0.23 in 2016, then tumbled by 105.86% to -$0.47 in 2017, then tumbled by 704.26% to -$3.78 in 2018, then skyrocketed by 99.74% to -$0.01 in 2019, then skyrocketed by 1100.0% to $0.1 in 2020.
- Its EPS (Basic) stands at $0.1 for Q4 2020, versus -$0.03 for Q3 2020 and -$0.04 for Q2 2020.